Govt. to augment Covaxin production by 10 crore doses
Financial support is being provided as a grant from the Government of India
Financial support is being provided as a grant from the Government of India
The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,
The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production
The facility is expected to be completed in 2024
Riding COVID-19 wave, Indian vaccine industry set to be Rs. 700 billion strong
Apart from the above, it was also decided that Basic Customs Duty on import of COVID-19 vaccines be also exempted with immediate effect for a period of 3 months
New manufacturing complex will occupy an overall footprint of approximately 2,000 square meter with six levels of manufacturing space
Against the present demand from 20 states of 6,785 MT/day of Liquid Medical Oxygen, the Government of India has from 21st April allocated 6,822 MT/day to these states
The country has constantly worked with the spirit of public-private partnership
The Department of Pharmaceuticals launched the PLI scheme for promoting domestic manufacturing of bulk drugs, with a financial outlay of Rs. 6,940 crore across 53 APIs over 6 years
Subscribe To Our Newsletter & Stay Updated